Predictive Genetic Testing Raises New Professional Challenges for Psychologists

Canadian Psychology

Volumn 45, Issue 1, 2004, Pages 16-30

  Pelletier, Sylvie ^a   Dorval, Michel ^b,c  

^a Université Laval ^*

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542320717     PISSN: 07085591     EISSN: None     Source Type: Journal    
DOI: 10.1037/h0086968     Document Type: Article

References (78)

1. American Society for Human Genetics (1994). Statement of the American Society for Human Genetics on genetic testing for breast and ovarian cancer predisposition. American Journal of Human Genetics, 55, i-iv.
2. American Society of Clinical Oncology (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. Journal of Clinical Oncology, 14, 1730-1736.
3. Baum, A., Friedman, A. L., & Zakowski, S. G. (1997). Stress and genetic testing for disease risk. Health Psychology, 16(1), 8-19.
4. Becker, M. H. (1974). The Health Belief Model and personal health behavior (Health Education Monographs). San Francisco, CA: Society for Public Health Education, Inc.
5. Botkin, J. R., Croyle, R. T., Smith, K. R., Baty, B. J., Lerman, C., Goldgar, D. E., Ward, J. M., Flick, J., & Nash, J. E. (1996). A model protocol for evaluating the behavioral and psychosocial effects of BRCA1 testing. Journal of the National Cancer Institute, 88(13), 872-881.
6. Bottorf, J. L., Ratner, P. A., Balneaves, L. G., Richardson, C. G., McCullum, M., Hack, T., Chalmers, K., & Buxton, J. (2002). Women's interest in genetic testing for breast cancer risk: The influence of sociodemographics and knowledge. Cancer Epidemiology, Biomarkers & Prevention, 11, 89-95.
7. Bowen, D. J., Patenaude, A. F., & Vernon, S. W. (1999). Psychosocial issues in cancer genetics: From the laboratory to the public. Cancer Epidemiology, Biomarkers & Prevention, 8, 326-328.
8. Briard, M.-L. (1997). Place de l'oncogénétique en médecine [The place of oncogenetics in medicine]. In Y. J. Bignon (Coord.), Oncogénétique - vers une médecine de présomption/prédiction (pp. 23-32). Paris: Technique et documentation Lavoisier.
9. Burgess, M. M., Laberge, C. M., & Knoppers, B. M. (1998). Bioethics for clinicians: 14. Ethics and genetics in medicine. Canadian Medical Association Journal, 158(10), 1309-1313.
10. Cabanac, J. (1999). Les test génétiques sur les mineurs: où en est l'éthique? [Ethical questions in the genetic gesting of minors]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 103-110). Québec: Presses de l'Université Laval.
11. Caulfield, T. (1999). Gene testing in the biothech century: Are physicians ready? Canadian Medical Association Journal, 161, 1122-1124.
12. Collins, F. S. (1999). Medical and societal consequences of the Human Genome Project. The New England Journal of Medicine, 341(1), 28-37.
13. Collins, F. S., & McKusick, V. A. (2001). Implications of the Human Genome Project for medical science. Journal of the American Medical Association, 285(7), 540-544.
14. Coyne, J. C., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. L. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68(5), 864-874.
15. Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychology, 16(1), 63-72.
16. Daull, F. (1997). Aspects éthiques en oncogénétique [Ethical aspects in oncogenetics] In Y. J. Bignon (Coord.), Oncogénétique - vers une médecine de présomption/prédiction (pp. 411-427). Paris: Technique et documentation Lavoisier.
17. Davis, A., Lapham, V., & Benkendorf, J. (1999). Continuing education workshop # 146: The new genetics - New and essential roles for psychologists. Paper presented at the 107th APA Annual Convention, Boston, MA.
18. Die-Trill, M., & Holland, J. (1995). A model curriculum for training in psycho-oncology. Psycho-Oncology, 4, 169-182.
19. Dorval, M., Patenaude, A. F., Schneider, K. A., Kieffer, S. A., DiGianni, L., Kalkbrenner, K. J., Bromberg, J. I., Basili, L. A., Calzone, K., Stopfer, J., Weber, B. L., & Garber, J. E. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. Journal of Clinical Oncology, 18(4), 2135-2142.
20. Eisinger, F., Alby, N., Bremond, A., Dauplat, J., Espie, M., Janiaud P., Kuttenn, F., Lebrun, J. P., Lefranc, J. P., Pierret, J., Sobol, H., Stoppa-Lyonnet, D., Thouvenin, D., Tristant, H., & Heingold, J. (1998). Recommendations for medical management of hereditary breast and ovarian cancer: The French National Ad Hoc Committee. Annals of Oncology, 9(9) 939-950.
21. Evers-Keibooms, G. (1995). Risk communication in genetic counselling and genetic risk perception. European Review of Applied Psychology, 45(1), 23-27.
22. Farmer, A., & Owen, M. J. (1996) Genomics: The next psychiatric revolution? British Journal of Psychiatry, 169, 135-138.
23. Feldman, W. (1994). Screening for phenylketonuria. In: Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care (pp. 159-188). Ottawa, ON: Canada Communication Group Publishing.
24. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., & Goldgar, D.E. (1994). Risks of cancer in BRCA1 mutation carriers. Lancet, 343, 692-695.
25. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Birch, J. M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y., Borg, A., Hamann, U., Haites, N., Scott, R. J., Maugard, C. M., Vasen, H., Seitz, S., Cannon-Albright, L. A., Schofield, A., Zelada-Hedman, M., & The Breast Cancer Linkage Consortium (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. American Journal of Human Genetics, 62, 676-689.
26. Freedman, T. G. (1998). Genetic susceptibility testing: Ethical and social quandaries. Health and Social Work, 23(3), 214-222.
27. Gagné, R., Mélançon, M. J., & Leclerc, B. (1999). L'information génétique en période prénatale: que faire? [Managing prenatal genetic information] In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 27-32). Québec: Presses de l'Université Laval.
28. Gaudet D. (1999). From DMA to the community. Community Genetics, 2(4), 139-140.
29. Glanz, K., & Lerman, C. (1992). Psychosocial impact of breast cancer: A critical review. Annals of Behavioral Medicine, 14(3), 204-212.
30. Hartmann, L. C., Schaid, D. J., Woods, J. E., Grotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., Frost, M. H., & Jenkins, R. B. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine, 340(2), 77-84.
31. International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921.
32. Jacobsen, P. B., Valdimarsdottir, H. B., Brown, K. L., & Offit, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine, 59, 459-466.
33. Janis, I. L., & Mann, L. (1976). Coping with decisional conflict. American Scientist, 64, 657-667.
34. Jenkins, J., Blitzer, M., Boehm, K., Feetham, S., Gettig, E., Johnson, A., Lapham, V., Patenaude, A. F., Reynolds, P., Guttmacher, A. E., & The Core Competency Working Group of the National Coalition for Health Professional Education in Genetics. (2001). Recommendations of core competencies in genetics essential for all health professionals. Genetics in Medicine, 3(2), 155-159.
35. Joncas, D. (1999). La santé génétique des Québécois: aspects juridiques. [The legal aspects of the genetic health of Quebecers]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 133-150). Québec: Presses de l'Université Laval.
36. Jordan, B. (1997). Du programme Génome à la pharma-cogénomique [From the Human Genome Project to pharmacogenomics]. Médecine-Sciences, 13(10), 1176-1178.
37. Julian-Reynier, C., Sobol, H., Sévilla, C., Noguès, C., Bourret, P., & The French Cancer Genetic Network. (2000). Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. Psycho-Oncology, 9, 504-510.
38. Kash, K. M., & Lerman, C. (1998). Psychological, social, and ethical issues in gene testing. In J. C. Holland et al. (Eds.), Psycho-Oncology (pp. 196-207). New York: Oxford University Press.
39. Kessler, S. (1979). The psychological foundations of genetic counseling. In S. Kessler (Ed.), Genetic counseling: Psychological dimensions (pp. 17-34). New York: Academic Press.
40. Kinney, A. Y., Croyle, R. T., Dudley, W. N., Bailey, C. A., Pelias, M. K., & Neuhausen, S. L. (2001). Knowledge, attitudes and interest in breast-ovarian cancer gene testing: A survey of a large African-American kindred with BRCA-1 mutation. Preventive Medicine, 33, 543-551.
41. Kinney, A. Y., Yeon-An, C., DeVellis, B., Millikan, R., Kobetz, E., & Sandler, R. S. (2000). Attitudes toward genetic testing in patients with colorectal cancer. Cancer Practice, 8(4.), 178-186.
42. Lambert, R. D., Mélançon, M. J., Gauthier, D., Lapointe, E., Kieller, G., & Gagné, R. (1999). La personne en génétique: un sujet ou un objet? [The individual in genetics: Subject or object?]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 199-225). Québec: Presses de l'Université Laval.
43. Lapham, E. V., Kozma, C., Weiss, J. O., Benkendorf, J. L., & Wilson, M. A. (2000). The gap between practice and genetics education of health professionals: HuGEM survey results. Genetics in Medicine, 2(4), July-August, 226-231.
44. Lazarus, R. S., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.
45. Leclerc, B. (2001). Conseil génétique [Genetic counseling]. In G. Hottois & J.-N. Missa (Under the direction of), Nouvelle encyclopédie de bioéthique (pp. 226-229). Bruxelles: De Boeck Université.
46. Leclerc, B., & Gagné, R. (1999). La validité du consentement au dépistage génétique. [Validity of consent in genetic screening]. In M. J. Mélançon & R. Gagné (Under the diretion of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 73-82). Québec: Presses de l'Université Laval.
47. Lee, P., & Hudson, T. J. (2000). La puce à ADN en médecine et en science [DNA chips in medicine and science]. Médecine/Sciences, 16(1), 43-49.
48. Léger, S. (1999). Le dépistage des porteur hétérozygotes: arguments de santé publique et aspects juridiques [Genetic screening of carriers: Public health arguments and legal aspects]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques el sociaux (pp. 151-162). Québec: Presses de l'Université Laval.
49. Lehmann, A. (1997). Aspects psychologiques de la consultation de conseil génétique [Psychological aspects of genetic counseling]. In Y. J. Bignon (Coord.), Oncogénélique - vers une médecine de présomption/prédiction (pp. 383-395). Paris: Technique et documentation Lavoisier.
50. Lerman, C., Biesecker, B., Benkendorf, J. L., Kerner, J., Gomez-Caminero, A., Hughes, C., & Reed, M. M. (1997). Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. Journal of the National Cancer Institute, 89(2), 148-157.
51. Lerman, C., & Croyle, R. (1994). Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine, 154(6), 609-616.
52. Lerman, C., Hughes, C., Lemon, S. J., Main, D., Snyder, C., Durham, C., Narod, S., & Lynch, H. T. (1998). What you don't know can hurt you: Adverse psychological effects in members of BRCA1 -linked and BRCA2-linked families who decline genetic testing. Journal of Clinical Oncology, 16(5), 1650-1654.
53. Lerman, C., Narod, S., Schulman, K., Hugues, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P., Lenoir, G., & Lynch, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275(24), 1885-1892.
54. Maugard, C. (1997). La consultation d'oncogénétique en pratique ou les nouveaux challenges de l'ère post-génomique [Oncongenetics counseling - New challenges in a postgenomic era]. In Y. J. Bignon (Coord.), Oncogénélique - vers une médecine de présomption/prédiction (pp. 57-67). Paris: Technique et documentation Lavoisier.
55. Mauron, A. (1999). Médecine prédictive et destinées individuelles: la tension entre équité actuarielle et justice sociale [Predictive medicine and individual fate: the tension between actuarial equity and social justice]. In M. J. Mélancon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 3-10). Québec: Presses de l'Université Laval.
56. Mélançon, M. J., Gauthier, D., Lapointe, E., Kieller, G., Gagné, R., & Lambert, R. D. (1999). Lignes directrices pour le stockage d'échantillons biologiques et pour la conservation d'informations génétiques [Guidelines for the storage of biological samples and genetic information]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 179-187). Québec: Presses de l'Université Laval.
57. National Advisory Council for Human Genome Research (1994). Statement on use of DNA testing for presymptomatic identification of cancer risk. Journal of the American Medical Association, 271, 785.
58. National Society of Genetic Counselors (1997). Predisposition genetic testing for late-onset disorders in adults: A position paper of the National Society of Genetic Counselors,. Journal of the American Medical Association, 278, 1217-1220.
59. Patenaude, A. F. (2001). Genetic testing and family relationships: Mutual impact and future implications. In B. R. Sarason & S. Duck, (Eds.), Personal relationships: Implications for clinical and community (pp. 43-59). New York: John Wiley & Sons.
60. Patenaude, A. F., Guttmacher, A. E., & Collins, F. S. (2002). Genetic testing and psychology: New roles, new responsibilities. American Psychologist, 57(4), 271-282.
61. Patenaude, A. F., Schneider, K. A., Kieffer, S. A., Calzone, K. A., Stopfer, J. E., Basili, L. A., Weber, B. L., & Garber, J. E. (1996). Acceptance of invitations for p53 and BRCA1 predisposition testing: Factors influencing potential utilization of cancer genetic testing. Psycho-Oncology, 5, 241-250.
62. Philips-Nootens, S. (1999). À la recherche de critères de légitimité: du discours éthique à la pratique [Towards legitimacy criteria: From ethical discourse to practice]. In M. J. Mćlançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 163-178). Québec: Presses de l'Université Laval.
63. Redelmeier, D. A., Rozin, P., & Kahneman, D. (1993). Understanding patients' decisions: Cognitive and emotional perspectives. Journal of the American Medical Association, 270(1), 72-76.
64. Rees, G., Fry, A., & Cull, A. (2001) A family history of breast cancer: Women's experiences from a theoretical perspective. Social Science and Medicine, 52, 1433-1440.
65. Roy, D. J., Williams J. R., Dickens, B. M., & Baudouin, J. L. (1995a). Le conseil génétique, le diagnostic prénatal et la thérapie fœtale [Genetic counseling, prenatal diagnosis and fœtal therapy]. In La bioéthique: ses fondements et ses controverses (pp. 181-209). Saint-Laurent: Éditions du renouveau pédagogique.
66. Roy, D. J., Williams, J. R., Dickens, B. M., & Baudouin, J. L. (1995b). Le projet du génome humain [The Human Genome Project]. In La bioéthique: ses fondements et ses controverses (pp. 481-510). Saint-Laurent: Éditions du renouveau pédagogique.
67. Shiloh, S. (1996). Genetic counseling: A developing area of interest for psychologists. Professional Psychology: Research and Practice, 27(5), 475-486.
68. Smith, K. R., & Croyle, R. T. (1995) Attitudes toward genetic testing for colon cancer risk. American Journal of Public Health, 85(10), 1435-1438.
69. Stiefel, F., Lehmann, A., & Guex, P. (1997). Genetic detection: The need for psychosocial support in modern cancer prevention. Supportive Care in Cancer, 5(6), 461-465.
70. Struewing J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.
71. Tremblay, G. (1999). Les parents face au dépistage géné tique [Parents and genetic screening]. In M. J. Mélançon & R. Gagné (Under the direction of), Dépistage et diagnostic génétiques. Aspects cliniques, juridiques, éthiques et sociaux (pp. 33-42). Québec: Presses de l'Université Laval.
72. Tversky, A., & Kahneman, D. (1974). Judgment under uncertainty: Heuristics and biases. Science, 185, 1124-1131.
73. Tversky, A., & Kahneman, D. (1981). The framing of decisions and the psychology of choice. Science, 211, 453-458.
74. Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., and 167 others (2001). The sequence of human genome. Science, 291, 1304-1351.
75. Vigne, D. (1998). Génétique des cancers: la quadrature du test [Genetics and cancer: Attempting the impossible]. Biofutur, 181, 20-23.
76. Walker, A. P. (1998). The practice of genetic counseling. In D. L. Baker, J. L. Schuette & W. R. Uhlmann (Eds.), A guide to genetic counseling (pp. 1-26). New York: Wiley-Liss.
77. Welch, H. G., & Burke, W. (1998). Uncertainties in genetic testing for chronic diseases. Journal of the American Medical Association, 250(17), 1525-1527.
78. Zhang, Y., & Zhang, M. (2001). A dictionary of gene technology terms. New York: The Parthenon Publishing Group.